BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Solution enables manufacturers to optimize manufacturing capacity, quality, efficiency and scalability 3M Separation and Purification Sciences announ...

November 01, 2021 | News

Xcell Therapeutics opens an export route for cell therapy culture technology.

In a hair follicle, there are "dermal follicle papilla cells" that appear 3,000 grapes clustered together. The name was given because its outline resemble...

October 29, 2021 | News

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high ...

October 28, 2021 | News

SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage

In the Phase 2a trial of a two stage adaptive design in OA patients with pain, OLP-1002 shall be evaluated for analgesic efficacy, safety and therapeutic d...

October 26, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

October 26, 2021 | News

AstraZeneca launches Clinical Data and Insights division in India

The Clinical Data & Insights team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data expe...

October 20, 2021 | News

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

The purpose of this Pre-Submission is to confirm with the FDA the clinical trial design, including trial objectives. This interaction will allow the FDA to...

October 20, 2021 | News

MYND to Participate in a Monash University (Australia) Proposal for $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF) is pleased to announce that the Company's pr...

October 18, 2021 | News

Biocytogen announces collaboration with Envigo

Biocytogen announces a collaboration with Envigo, a global organization that offers the widest range of research models and related services. The two compa...

September 29, 2021 | News

ACROMEC's associated Life Science Incubator launches Co-working Labspace

ACROMEC Limited a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture a...

September 24, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

September 23, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

September 21, 2021 | News

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

September 14, 2021 | News

Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine

First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...

September 11, 2021 | News

Stay Connected